Activated protein C resistance and pregnancy - MÃDICA - a Journal ...
Activated protein C resistance and pregnancy - MÃDICA - a Journal ...
Activated protein C resistance and pregnancy - MÃDICA - a Journal ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
M K pag 105<br />
M K pag 105<br />
ACTIVATED PROTEIN C RESISTANCE AND PREGNANCY – DEPARTMENT’S OF HAEMATOLOGY, COLTEA CLINICAL HOSPITAL EXPERIENCE<br />
REFERENCES<br />
1. Dahlback B, Carlsson M, Svensson<br />
PJ – Familial thrombophilia due to a<br />
previously unrecognized mechanism<br />
characterized by poor anticoagulant<br />
response to activated <strong>protein</strong> C:<br />
Prediction of a cofactor to activated<br />
<strong>protein</strong> C. Proc. Natl. Acad Sci. 1993;<br />
90:1004-1008<br />
2. Bernardi F, Faioni EM, Castoldi E,<br />
et al. – A factor V genetic component<br />
differing from factor V R506Q<br />
contributes to the activated <strong>protein</strong> C<br />
<strong>resistance</strong> phenotype. Blood 1997;<br />
90:1552-1557<br />
3. Williamson D, Brown K,<br />
Luddington R, Baglin C, Baglin T –<br />
Factor V Cambridge: A new mutation<br />
(Arg 306 àThr) associated with<br />
<strong>resistance</strong> to activated <strong>protein</strong> C.<br />
Blood 1998; 91:1140-1144<br />
4. Clark P, Walker DI – The phenomenon<br />
known as acquired <strong>protein</strong> C<br />
<strong>resistance</strong>. British J of Haematology<br />
2001; 115:767-773<br />
5. Ehrenforth S, Radtke KP, Scharrer I –<br />
Acquired activation <strong>protein</strong> C-<strong>resistance</strong><br />
in patitents with lupus anticoagulants.<br />
Thromb Haemost 1995; 74:797<br />
6. Green D, Maliekel K, Sushko E, et<br />
al – <strong>Activated</strong> <strong>protein</strong> C <strong>resistance</strong> in<br />
cancer patients. Haemostasis 1997;<br />
27:112-118<br />
7. Oosting JD, Derksen RH, Bubbink<br />
IW, et al – Antiphospholipid<br />
antibodies directed against a combination<br />
of phospholipids with prothrombin,<br />
<strong>protein</strong> C, or <strong>protein</strong> S: an<br />
explanation for their pathogenic<br />
mechanism. Blood 1993; 81: 2618-2625<br />
8. Lindqvist PG, Svensson P,<br />
Dahlback B – <strong>Activated</strong> <strong>protein</strong> C<br />
<strong>resistance</strong> in the absence of factor V<br />
Leiden <strong>and</strong> <strong>pregnancy</strong>. J Thromb<br />
Haemost 2006; 4:361–6.<br />
9. Brenner B – Haemostatic changes in<br />
<strong>pregnancy</strong>. Thromb Res. 2004; 114(5-<br />
6):409-414<br />
10. Bremme KA – Haemostatic changes<br />
in <strong>pregnancy</strong>. Best Pract Res Clin<br />
Haematol 2003; 16:153-168<br />
11. Margareta Hellgren – Hemostasis<br />
during Normal Pregnancy <strong>and</strong><br />
Puerperium. Semin Thromb Hemost<br />
2003; 29:125-130<br />
12. Mathonnet F, de Mazancourt P,<br />
Bastenaire B, et al – <strong>Activated</strong><br />
<strong>protein</strong> C sensitivity ratio in pregnant<br />
women at delivery. Br J Haematol<br />
1996; 92:244-246<br />
13. Rai R, Backos M, Elgaddal S, et al –<br />
Factor V Leiden <strong>and</strong> recurrent<br />
miscarriage-prospective outcome of<br />
untreated pregnancies. Hum. Reprod.<br />
2002; 17:442-445<br />
14. Giorgio Mello, Elena Parretti, Luca<br />
Marozio, et al – Thrombophilia Is<br />
Significantly Associated With Severe<br />
Preeclampsia. Hypertension 2005;<br />
46:1270<br />
15. Nurk E, Tell GS, Refsum H, et al –<br />
Factor V Leiden, <strong>pregnancy</strong><br />
complications <strong>and</strong> adverse outcomes:<br />
the Hordal<strong>and</strong> Homocysteine Study.<br />
QJM 2006; 99:289-298<br />
16. Farquharson RG, Jauniaux E, Exalto<br />
N – Updated <strong>and</strong> revised<br />
nomenclature for description of early<br />
<strong>pregnancy</strong> events. Hum Reprod 2005;<br />
20:3008-3011<br />
17. Infante-Rivard C, Rivard GE,<br />
Guiguet M, et al – Thrombophilic<br />
polymorphisms <strong>and</strong> intrauterine<br />
growth restriction. Epidemiology 2005;<br />
16:281-287<br />
18. Kupferminc MJ, Many A, Bar-Am<br />
A, et al – Mid-trimester severe<br />
intrauterine growth restriction is<br />
associated with a high prevalence of<br />
thrombophilia. BJOG 2002; 109:1373-<br />
1376<br />
19. Prochazka M, Lubusky M, Slavik L,<br />
et al – Frequency of selected<br />
thrombophilias in women with<br />
placental abruption. Aust NZ J Obstet<br />
Gynaecol 2007; 47:297-301<br />
20. Hvas AM, Ingerslev J, Salvig JD –<br />
Thrombophilia risk factors are<br />
associated with intrauterine fetal<br />
death <strong>and</strong> <strong>pregnancy</strong>-related venous<br />
thromboembolism. Sc<strong>and</strong> J Clin Lab<br />
Invest. 2008; 21:1-7<br />
21. Michael J Kupferminc –<br />
Thrombophilia <strong>and</strong> <strong>pregnancy</strong>. Reprod<br />
Biol Endocrinol 2003; 1:111<br />
22. Middeldorp S – Thrombophilia <strong>and</strong><br />
<strong>pregnancy</strong> complications: cause or<br />
association J Thromb Haemost 2007; 5<br />
(Suppl. 1):276-282<br />
23. Greer IA – The Challenge of<br />
Thrombophilia in Maternal-Fetal<br />
Medicine. N Engl Med 2000, 342:424-425<br />
24. Brill-Edwards P, Ginsberg JS, Gent<br />
M, et al – Safety of withholding<br />
heparin in pregnant women with a<br />
history of venous thromboembolism.<br />
Recurrence of Clot in This Pregnancy<br />
Study Group. N Engl J Med 2000;<br />
343:1439-1444<br />
25. Leduc L, Dubois E, Takser L, et al –<br />
Dalteparin <strong>and</strong> low-dose aspirin in<br />
the prevention of adverse obstetric<br />
outcomes in women with inherited<br />
thrombophilia. J Obstet Gynaecol Can.<br />
2007; 29(10):787-793<br />
26. Middeldorp S – Pregnancy failure<br />
<strong>and</strong> heritable thrombophilia. Semin<br />
Hematol. 2007; 44(2):93-97<br />
27. Brenner B, Aharon A – Thrombophilia<br />
<strong>and</strong> adverse <strong>pregnancy</strong><br />
outcome. Clin Perinatol. 2007;<br />
34(4):527-541<br />
Mædica A <strong>Journal</strong> of Clinical Medicine, Volume 4 No.2 2009 105